# Retapamulin as a Decolonizing Agent for MRSA

> **NCT03304873** · PHASE3 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 47 (actual)

## Conditions studied

- MRSA

## Interventions

- **DRUG:** Retapamulin
- **DRUG:** Placebo Ointment

## Key facts

- **NCT ID:** NCT03304873
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-01
- **Primary completion:** 2019-02-13
- **Final completion:** 2019-03-18
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2020-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03304873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03304873, "Retapamulin as a Decolonizing Agent for MRSA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03304873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*